AZD4017
Showing 1 - 9 of 9
Idiopathic Intracranial Hypertension Trial in Birmingham (AZD4017, Placebo)
Completed
- Idiopathic Intracranial Hypertension
- AZD4017
- Placebo
-
Birmingham, West Midlands, United KingdomUniversity Hospital Birmingham (Queen Elizabeth Hospital)
Sep 28, 2021
Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)
Completed
- Iatrogenic Cushing's Disease
- AZD4017 and prednisolone
- Placebo Oral Tablet and prednisolone
-
Oxford, United KingdomUniversity of Oxford
May 12, 2021
Diabetes, Type 2 Trial in Leeds (AZD4017, Placebo)
Completed
- Diabetes Mellitus, Type 2
- AZD4017
- Placebo
-
Leeds, United KingdomLeeds Teaching Hospitals Trust
Mar 21, 2019
COPD COPD Trial in Worldwide (AZD7624 1.0 mg, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease COPD
- AZD7624 1.0 mg
- Placebo
-
Los Angeles, California
- +40 more
Apr 26, 2018
Raised Intraocular Pressure Trial in Sweden, United Kingdom, United States (AZD4017, Placebo)
Completed
- Raised Intraocular Pressure
- AZD4017
- Placebo
-
Newport Beach, California
- +10 more
Jan 20, 2014
Obesity Trial in Goteborg (AZD4017, Placebo)
Completed
- Obesity
- AZD4017
- Placebo
-
Goteborg, SwedenResearch Site
Dec 9, 2010
Diabetes Type 2 Trial in Gothenburg (AZD4017, Placebo)
Completed
- Diabetes Mellitus Type 2
- AZD4017
- Placebo
-
Gothenburg, SwedenResearch Site
Sep 29, 2009
Healthy Trial in Fukuoka (AZD4017, Placebo)
Completed
- Healthy
- AZD4017
- Placebo
-
Fukuoka, JapanResearch Site
Jun 30, 2009
Healthy Trial in Gotteborg (AZD4017, Placebo)
Completed
- Healthy
- AZD4017
- Placebo
-
Gotteborg, SwedenResearch Site
Jun 15, 2009